NCT06430450View on ClinicalTrials.gov

Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin 3, IL-4, IL-10 and TNF-α Levels in Individuals With Different Degrees of Periodontal Disease

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

November 15, 2024

Study Completion Date

January 15, 2025

Conditions
PeriodontitisPeriodontal Diseases
Interventions
DIAGNOSTIC_TEST

Clinical measurements and saliva samples collection

Clinical measurements will be taken from all patients and saliva samples will be collected for biochemical analysis.

All Listed Sponsors
lead

Karamanoğlu Mehmetbey University

OTHER

NCT06430450 - Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin 3, IL-4, IL-10 and TNF-α Levels in Individuals With Different Degrees of Periodontal Disease | Biotech Hunter | Biotech Hunter